Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease 2024-05-03 19:00
QANDA Named to TIME's Inaugural List of the World's Top EdTech Companies in 2024 2024-05-03 07:27
Boryung Launches 2024 Humans In Space Challenge: Sending Experiments into Orbit 2024-05-02 20:00
Hanwha Launches Engine Leasing Platform 2024-05-02 17:30
Korea Electric Power Corporation Files 2023 Annual Report on Form 20-F 2024-05-01 04:22
Bebefinn Expands with Its First Live Show, "Bebefinn LIVE - Bedtime Adventure" 2024-04-30 21:05
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update 2024-04-30 19:00
KT Corp. Files 2023 Annual Report on Form 20-F 2024-04-30 18:49
Hurom Takes Global Action to Protect Juicer Patents 2024-04-29 21:00
Medit launches the revolutionary i900, an intraoral scanning system set to redefine the scanning experience for dental clinics worldwide 2024-04-29 21:00
WOORI FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F 2024-04-29 20:25
POSCO HOLDINGS INC. Files its Annual Report on Form 20-F 2024-04-29 19:26
SK TELECOM CO. LTD. FILES ITS ANNUAL REPORT ON FORM 20-F 2024-04-29 19:25
Driving Impact with AI: Brian Impact Foundation Joins AVPN Global Conference 2024 2024-04-26 20:00
KB FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F 2024-04-26 19:34
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil 2024-04-25 21:41
On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference 2024-04-25 21:00
LG Innotek awarded at 'Edison Awards,' the most prestigious invention award in the US for the second consecutive year 2024-04-25 20:00
POSCO International achieves solid first quarter results for fiscal year 2024 despite global economic downturn 2024-04-25 18:41
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer 2024-04-25 17:11
1 2 3 4 5 145